In the last trading session, 1.25 million shares of the NeoGenomics Inc. (NASDAQ:NEO) were traded, and its beta was 0.63. Most recently the company’s share price was $32.77, and it changed around -$2.51 or -7.11% from the last close, which brings the market valuation of the company to $4.04B. NEO currently trades at a discount to its 52-week high of $61.57, offering almost -87.89% off that amount. The share price’s 52-week low was $29.66, which indicates that the current value has risen by an impressive 9.49% since then. We note from NeoGenomics Inc.’s average daily trading volume that its 3-month average coming to 900.27K.
NeoGenomics Inc. stock received a consensus recommendation rating of a Buy, based on a mean score of 1.60. If we narrow it down even further, the data shows that 0 out of 12 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 1 recommended NEO as a Hold, whereas 10 deemed it a Buy, and 0 rated it as Underweight. NeoGenomics Inc. is expected to report earnings per share of -$0.08 for the current quarter.
3 Tiny Stocks Primed to Explode The world’s greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We’ve set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Instantly NEO has showed a red trend with a performance of -7.11% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 35.34 on Tuesday, 01/04/22 increased the stock’s daily price by 7.27%. The company’s shares are currently down -3.96% year-to-date, but still up 0.61% over the last five days. On the other hand, NeoGenomics Inc. (NASDAQ:NEO) is 7.48% up in the 30-day period.
The consensus price target as assigned by Wall Street analysts is $50.18, which translates to bulls needing to increase their stock price by 34.7% from its current value. Analyst projections state that NEO is forecast to be at a low of $41.00 and a high of $60.00. In order for the stock price to hit the forecast high, the stock would need to plunge -83.09% from its current level, while the stock would need to crash -25.11% from its current level to reach the projected low.
NeoGenomics Inc. (NEO) estimates and forecasts
NeoGenomics Inc. share prices are performing particularly well not compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -27.40 percent over the past six months and at a -280.00% annual growth rate that is well below the industry average of 7.70%. Moreover, analysts have decided to roll up on their fiscal year 2022 revenue estimates. The rating firms predict that it will loss -233.30% in revenue this quarter, and will report a decrease of -150.00% in the next quarter. The year-over-year growth rate is expected to be 12.40%, up from the previous year.
Consensus estimates provided by 11 financial analysts predict the company will bring in an average of $126.59 million in revenue for the current quarter. 11 analysts expect NeoGenomics Inc. to make $135.69 million in revenue for the quarter ending Dec 2021. The company’s sales for the same quarters a year ago were $125.44 million and $126 million respectively. Analysts predict that the company’s current quarter sales will jump, forecast at 0.90%. Forecasts for the next quarter put sales growth at 7.70%.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 23.30%. NeoGenomics Inc. earnings are expected to increase by -51.70% in 2022, but the outlook is positive 12.30% per year for the next five years.
NeoGenomics Inc.’s next quarterly earnings report is expected to be released around February 22 and February 28.
NeoGenomics Inc. (NASDAQ:NEO)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 4.04% of NeoGenomics Inc. shares, and 95.90% of them are in the hands of institutional investors. The stock currently has a share float of 99.93%. NeoGenomics Inc. stock is held by 441 institutions, with Blackrock Inc. being the largest institutional investor. By Sep 29, 2021, it held 15.24% of the shares, which is about 18.76 million shares worth $904.94 million.
Vanguard Group, Inc. (The), with 10.29% or 12.67 million shares worth $611.22 million as of Sep 29, 2021, holds the second largest percentage of outstanding shares.
iShares Core S&P Smallcap ETF and Vanguard Total Stock Market Index Fund were the top two Mutual Funds as of Sep 29, 2021. The former held 8.18 million shares worth $394.39 million, making up 6.64% of all outstanding shares. On the other hand, Vanguard Total Stock Market Index Fund held roughly 3.17 million shares worth around $143.39 million, which represents about 2.58% of the total shares outstanding.